Cited by 807Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseViral Infections and Immunology Research

The DOI matches its Crossref record; 518 of the 518 references it cites were found in a registry or an index.

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Ommen, Steve R., Ho, Carolyn Y., Asif, Irfan M., Balaji, Seshadri, Burke, Michael A., Day, Sharlene M., Dearani, Joseph A., Epps, Kelly C., Evanovich, Lauren, Ferrari, Victor A., Joglar, José A., Khan, Sadiya S., Kim, Jeffrey J., Kittleson, Michelle M., Krittanawong, Chayakrit, Martinez, Matthew W., Mital, Seema, Naidu, Srihari S., Saberi, Sara, Semsarian, Christopher, Times, Sabrina, Waldman, Cynthia Burstein·2024·Circulation

DOI 10.1161/cir.0000000000001250

Open this paper in CoChat — free account

Abstract

AIM: The “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy” provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. METHODS: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE: Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy” have been updated with new evidence to guide clinicians.

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000001250

Cites

518 of 518 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
The Physical Activity Guidelines for Americans
Piercy, K. L., Troiano, R. P., Ballard, R. M., Carlson, S. A., Fulton, J. E., Galuska, D. A., George, S. M., & Olson, R. D. (2018) · JAMA · doi:10.1001/jama.2018.14854 · Cited by 9,755
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
2011 Compendium of Physical Activities: A Second Update of Codes and MET Values
AINSWORTH, B. E., HASKELL, W. L., HERRMANN, S. D., MECKES, N., BASSETT, D. R., TUDOR-LOCKE, C., GREER, J. L., VEZINA, J., WHITT-GLOVER, M. C., & LEON, A. S. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31821ece12 · Cited by 6,317
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J., Erdmann, E., Freemantle, N., Gras, D., KAPPENBERGER, L. J., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,300
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Self-citation
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686

Show all 514 references

Research works printed but not linked: 227

Committee on Standards for Systematic Reviews of Comparative Effectiveness Research Institute of Medicine (US). Finding What Works in Health Care: Standards for Systematic Reviews. National Academies Press; 2011.
Animal Studies-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/54.
Guidelines-Broad-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/75.
Guidelines-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/77.
RCT/ CCT-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/108.
SR/ MA/ HTA/ ITC-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022: Accessed September 14, 2022. https://searchfilters.cadth.ca/link/99.
10.1016/s0025-6196(11)64198-0 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1001/jamacardio.2015.0354 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1016/j.jacc.2015.01.019 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1016/j.jacc.2018.10.007 · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ehjci/jew313 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.01.071 · DOI
10.1016/j.jacc.2012.03.076 · DOI
10.1016/j.jacc.2010.11.002 · DOI
10.1016/j.echo.2011.03.006 · DOI
10.1161/circulationaha.107.698985 · DOI
10.1016/j.jcin.2011.02.014 · DOI
10.1016/j.amjcard.2007.09.111 · DOI
10.1161/01.cir.0000097110.55312.bf · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ejechocard/jeq063 · DOI
10.1093/ehjci/jew313 · DOI
10.1136/hrt.2007.126003 · DOI
10.1056/nejmoa021332 · DOI · Paper page
10.1016/s0002-9149(99)80416-0 · DOI
10.1161/01.cir.0000162460.36735.71 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1161/hcg.0000000000000054 · DOI
10.1093/eurheartj/ehq271 · DOI
10.1016/j.jacc.2012.02.068 · DOI
10.1161/circgen.117.001896 · DOI · Paper page
10.1161/circulationaha.114.013478 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1016/j.hrthm.2011.07.017 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1161/circgenetics.116.001620 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jacc.2015.01.019 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.118.037264 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jpeds.2017.03.033 · DOI
10.1093/eurheartj/ehr092 · DOI · Paper page
10.1148/radiol.2018180339 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.echo.2011.03.002 · DOI
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.120.047235 · DOI
10.1111/cge.13157 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1161/circulationaha.122.062699 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1001/jamacardio.2019.2861 · DOI
10.1001/jamacardio.2018.0789 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1177/2047487317702519 · DOI
10.1161/circheartfailure.113.000414 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1111/chd.12286 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1111/cge.13157 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.122.062699 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1056/nejm200006153422403 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1017/s1047951105001824 · DOI
10.1038/nrcardio.2017.6 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1001/jama.298.4.405 · DOI
10.1016/j.ahj.2013.06.009 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1093/eurheartj/ehq308 · DOI
10.1056/nejm200006153422403 · DOI
10.1016/j.jacc.2004.12.067 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1093/eurheartj/eht439 · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2013.01.037 · DOI
10.1177/2047487317702519 · DOI
10.1007/s00246-011-9967-y · DOI
10.1016/s0735-1097(98)00493-8 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1007/s00246-013-0676-6 · DOI
10.1161/circulationaha.115.017633 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jcmg.2016.02.031 · DOI
10.1016/j.jacc.2018.05.060 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1161/circulationaha.112.136085 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1016/j.amjcard.2020.04.042 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1016/j.jacc.2009.03.051 · DOI
10.1016/j.jacc.2013.01.037 · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/cir.0000000000000628 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.jacc.2015.06.1333 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.amjcard.2013.01.340 · DOI
10.1016/j.jcmg.2013.08.010 · DOI
10.1001/jamacardio.2016.0252 · DOI
10.1016/j.jtcvs.2018.11.148 · DOI
10.1016/j.mayocp.2018.07.022 · DOI
10.1016/j.jacc.2016.07.735 · DOI · Paper page
10.1016/j.echo.2018.10.011 · DOI
10.1136/hrt.2007.118018 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1161/01.cir.0000162460.36735.71 · DOI
Liebregts, M, Vriesendorp, PA, Mahmoodi, BK, et al. A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol HF. 2015;3:896–905.
10.1536/ihj.27.701 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1161/01.cir.0000097110.55312.bf · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/circulationaha.105.583500 · DOI
10.1093/eurheartj/ehq136 · DOI
10.1161/circheartfailure.114.002248 · DOI · Paper page
10.1253/circj.cj-16-0432 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1016/s0140-6736(20)31792-x · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1016/j.ejheart.2008.03.006 · DOI
Gu, M, Jin, H, Hua, W, et al. Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy. J Geriatr Cardiol. 2017;14:238–244.
10.1016/j.jacc.2017.11.040 · DOI
10.1093/europace/euw327 · DOI
Rowin, EJ, Mohanty, S, Madias, C, et al. Benefit of cardiac resynchronization therapy in end-stage nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol EP. 2019;5:131–133.
10.1136/heartjnl-2013-305471 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1161/circheartfailure.114.001843 · DOI · Paper page
10.1016/s2213-8587(14)70241-4 · DOI
10.1016/j.amjcard.2016.08.092 · DOI
10.1111/jce.12982 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1016/j.jacc.2005.01.012 · DOI · Paper page
10.1161/jaha.116.005152 · DOI
10.1016/j.amjcard.2003.10.025 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1161/circheartfailure.114.001435 · DOI
10.1161/circep.110.957290 · DOI

200 of 227 shown

Sorted by citations

Items 401–500 of 806

Valor Prognóstico da Taquicardia Ventricular não Sustentada na Miocardiopatia Hipertrófica em Coorte Brasileira: Comparação com Literatura Mundial
Silva, D. A., Arteaga-Fernández, E., Hotta, V. T., Mady, C., Ianni, B. M., Ramires, F. J. A., Nastari, L., Fernandes, F., & Cardoso, J. N. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240399 · Cited by 1
Morte cardiaca improvvisa negli atleti: focus sulle strategie di analisi genetiche per una prevenzione precoce
Nunziato, M. (2025) · Biochimica Clinica · doi:10.23736/s0393-0564.25.00055-x · Cited by 1
Infantile Hypertrophic cardiomyopathy: steps towards an evidence-based approach to genetic testing
Norrish, G., & Kaski, J. P. (2025) · Pediatric Research · doi:10.1038/s41390-025-04188-6 · Cited by 1
Incidence of cardiovascular risk factors and exercise phenotyping in cardiomyopathies: One size does not fit all
Wernhart, S., Karcher, F., Haykowsky, M. J., & Halle, M. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101722 · Cited by 1
Dynamic Changes of Distinct Compartmental LV Remodeling Following Septal Myectomy in Hypertrophic Obstructive Cardiomyopathy
Luo, X., Lu, G., Liu, Z., Chen, Y., Ou, J., Wu, H., Zhu, W. Z., Chen, R., Guo, H. M., Liu, H., et al. (2025) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.125.018131 · Cited by 1
Morte súbita em atletas: Uma análise do perfil de acometimento a partir de relato de casos
Bená, T. D. C., Salci, G. S., Godoy, I. F. A., Maeda, L. M., Sartorelli, M. P. F., Carrinho, M., & Ruivo, G. F. (2025) · Research Society and Development · doi:10.33448/rsd-v14i10.49642 · Cited by 1
New Perspectives on Early Stage Hypertrophic Cardiomyopathy: Measuring What Matters
Goldie, F. C., & COATS, C. J. (2024) · Circulation Heart Failure · doi:10.1161/circheartfailure.124.012093 · Cited by 1
Is Simpler Better? The Psychometric Performance of the Kansas City Cardiomyopathy Questionnaire-12 in Symptomatic Obstructive Cardiomyopathy
Gamero, M. T., Soles, E. O., & Brailovsky, Y. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.03.007 · Cited by 1
Obstruction in Hypertrophic Cardiomyopathy: Don't Forget Midventricular Obstruction
Gilreath, K. M., & Geske, J. B. (2025) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2025.05.014 · Cited by 1
Refining sudden cardiac death risk in hypertrophic cardiomyopathy: The interplay between atrial and ventricular arrhythmias
Kukuev, A., Ravid, D., & Rader, F. (2026) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2026.04.010 · Cited by 1
Hypertension management in obstructive hypertrophic cardiomyopathy patients treated with cardiac myosin inhibitors - real world data
Paik, K. S., Wright, Z., Gokul, K., Seals, A., Raman, D., & Sundaravel, S. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134661
Use of Disopyramide in Obstructive Hypertrophic Cardiomyopathy: A European Insight
Charron, P., Osman, F., Trochu, J., Zema, C., Hurst, M. A., Sandler, B. C., Cotté, F.-E., Lemmer, T., & Tome, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15114234
Sarcomere gene mutations in hypertrophic cardiomyopathy: how to clinically manage this information?
Sanna, G. D., & Finocchiaro, G. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132373
Case Report: Left ventricular apical hypertrophy in a patient with Leopard syndrome mimicking a cardiac tumor: a diagnostic challenge resolved by multimodality imaging
Liu, H., Zheng, Y., Huo, H., Peng, X., Yang, J., Ma, C., & Liu, T. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1378078
Anticoagulation in patients with atrial fibrillation and chronic kidney disease: clinical complexity beyond thromboembolism
Buoninfante, G., Basili, S., & Romiti, G. F. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-024-03733-1
Early Versus Late Initiation of Warfarin Post-Cesarean Section: A Step Forward in Managing Mechanical Heart Valve Patients
Choi, Y. (2024) · Korean Circulation Journal · doi:10.4070/kcj.2024.0228
HCM-associated mutations in MYH6/7 drive pathologic expression of TGF-β1 in cardiomyocytes within weeks of developmental specificationPreprint
Hsieh, J., Hall, M. A. L., Shameem, M., Erñst, P., Kamdar, F. D., Singh, B. N., Meisel, R. L., & Ogle, B. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.08.606705
From Editor-in-Chief: Our Hirsch index, current issue, news from ESC 2024, trials and new guidelines, protection and long COVID
Kudaiberdieva, G. (2024) · Heart Vessels and Transplantation · doi:10.24969/hvt.2024.510
Navigating Hypertension in Hypertrophic Obstructive Cardiomyopathy: A Cardiovascular Conundrum
Dooley, S. W., Tahir, U. A., & Cluett, J. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23347
What the blood knows: predicting atrial fibrillation risk in hypertrophic cardiomyopathy patients
Jabbour, G., Tadros, R., & Remme, C. A. (2024) · EP Europace · doi:10.1093/europace/euae268
Cardiomiopatía hipertrófica asociada a variante genética en MYBPC3:c.1119 C>G (p.Tyr373Ter)
Meza, J. S. H., Tovio, J. J. G., Meza, S. A. H., & Niederbacher, N. (2024) · Revista Argentina de Cardiología · doi:10.7775/rac.v92.i5.20818
Left ventricular mechanics analysis after endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy
Morales-Portano, J. D., Ortiz-Ávalos, M., Rodríguez-Diez, G., Andrade-Cuellar, E. N., Lara-Vargas, J. A., & Vannan, M. A. (2024) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2024.11.009
Calling the Right Plays in Hypertrophic Cardiomyopathy: Are Our Blockers Optimized for the Game?
Alaiwi, S. A., & Rosenfeld, L. E. (2024) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2024.11.025
Getting to the ‘Heart’ of Climate Change
Stewart, S. (2024) · Sustainable development goals series · doi:10.1007/978-3-031-73106-8_2
Outcomes of a multidisciplinary approach to management of mavacamten in obstructive hypertrophic cardiomyopathy
Jensen, H., Yousif, Z. K., Huynh, T., Kraushaar, M., Reed, M., Boarman, T., Enciso, J. S., & Willeford, A. (2024) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxae372
Hyperenhancement of LA Wall by Three-Dimensional High-Resolution Late Gadolinium-Enhanced MRI and Recurrence of AF After Catheter Ablation
Kagimoto, M., Kato, S., Takizawa, R., Kodama, S., Suzurikawa, K., Azuma, M., Nakayama, N., Iguchi, K., Fukui, K., Ito, M., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237357
Genetic Causes of Sudden Cardiac Arrest in the CommunityPreprint
Kransdorf, E. P., Mathias, M., Nakamura, K., Tyrer, J. P., Pharoah, P. D. P., Chugh, H. S., Reinier, K., Coban‐Akdemir, Z., Boerwinkle, E., Yu, B., et al. (2024) · medRxiv · doi:10.1101/2024.12.08.24318665
Asymptomatic But Obstructive
Bilen, O., & Burke, M. A. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2024.10.017
Self-citation
The design and rationale of the cardiac REHABilitation to improve metabolic health in Hypertrophic CardioMyopathy (REHAB-HCM) Study
Cheung, M. A., Moulson, N., Gelinas, J. C., Daraei, A., Bradwell, S. M., Taylor, C. M., Eves, N. D., Koelwyn, G. J., & Roston, T. M. (2025) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2025.100501
Cardiac Plasticity in Hypertrophic Cardiomyopathy: Exercise as Medicine?
MacNamara, J. P., & Ayers, M. P. (2025) · Circulation · doi:10.1161/circulationaha.124.072649
Prognosis of pulmonary hypertension in patients with hypertrophic cardiomyopathy: A multicenter propensity score matching study
Ma, H., Xu, F., Liu, L., Kong, H., Luo, R., Liu, M., Liu, T., & Li, X. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101605
Medicare Coverage and Patient Out-of-Pocket Costs for Mavacamten
Bansal, K., Chien, C., Masri, A., Riello, R. J., Ahmad, T., Desai, N. R., & Dani, S. S. (2025) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.124.011331
Guías mexicanas 2024 para el diagnóstico y tratamiento de la miocardiopatía hipertrófica
Llamas‐Esperón, G. A., Berrios-Bárcenas, E. A., Cossío-Aranda, J. E., Guerra-López, A., Magaña‐Serrano, J. A., Iturralde-Torres, P., Lara-Vargas, J. A., Meave‐González, A., Rosas, E. A., Ilazarra-Lomelí, H., et al. (2025) · Archivos de cardiología de México · doi:10.24875/acm.m25000098
Additive Predictive Value of Left Ventricular End-Diastolic Volume Index to the Development of Persistent Atrial Fibrillation in Nonobstructive Hypertrophic Cardiomyopathy
Tang, Y., Pan, Y., Xiao, M., Song, L., Lu, M., & Zheng, Z. (2025) · Cardiology · doi:10.1159/000544032
Hypertrophic Cardiomyopathy Combined with Renal and Adrenal Aplasia in a Male with Noonan Syndrome from RAF1 Variant
Wang, Y., Ma, G., Cai, D., Yao, J., Huang, B., Wu, C.-C., Liu, X., & Cai, Z. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15239
Using machine learning to guide imaging in hypertrophic cardiomyopathy - from lessening the burden of our day-to-day clinical decisions to more cost-effective resource utilization
Florian, A. R. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133059
AAD in Patients with Comorbidities
Sartiani, L., & Cerbai, E. (2024) · Springer eBooks · doi:10.1007/978-3-031-74046-6_14
Cardiac Manifestations in Children of Diabetic Mothers and Fathers
Huhulea, E. N., Huang, L., Aifuwa, E., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000887
Editorial commentary: Atrial fibrillation in patients with cardiomyopathy – Protecting the vulnerable
Salazar, J. W., & Morin, D. P. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.02.011
Hypertrophe Kardiomyopathie
Veselka, J., Franz, M., & Ibrahim, K. S. (2025) · Kardiologie up2date · doi:10.1055/a-2384-8004
HCM's hidden cost: The impact of socioeconomic status
Park, C. M., Schenone, A. L., & Masri, A. (2025) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2025.03.011
Provocation Testing for Left Ventricular Outflow Tract Obstruction in Patients Presenting for Concurrent Cardiac Procedures
Obianagha, C., Holloway, J. O., Wernke, C., Toma, N., Ma, L., Essandoh, M. K., Jean-Baptiste, L., Adjapong, A., Henn, M. C., & Tang, J. E. (2025) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2025.03.042
A Primer on the Surgical Management of Hypertrophic Cardiomyopathy
Hassanabad, A. F., McKenzie, M. P., Shanmugam, G., & Kent, W. D. T. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.03.029
DGK-Manual zum Stellenwert der Ergometrie
Klingenheben, T., Bauersachs, J., Bosch, R., von Haehling, S., Hellhammer, K., & Tiefenbacher, C. (2025) · Die Kardiologie · doi:10.1007/s12181-025-00739-7
Global, Regional, and National Burden Of Cardiomyopathy and Myocarditis: Deaths, Prevalence, and Dalys from 1990 to 2021 Based on the Global Burden of Disease StudyPreprint
Xu, X., Li, Z., Li, H., Deng, J., Zhang, W., Zhang, C., & Shi, L. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5209478
Bleeding with a Thick Heart: A Rare Case of Lower Gastrointestinal Bleeding in Hypertrophic Obstructive Cardiomyopathy—A Case Report and Comprehensive Literature Review
Ndakotsu, A. K., Iyeku, A. C., Vasireddy, R., Akhiwu, T. O., & Osei, A. D. (2025) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-01847-x
Association between programmed electrical stimulation inducibility and arrhythmic risk in hypertrophic cardiomyopathy: a systematic review and meta-analysis
Salihu, A., Antiochos, P., Lu, H. Y., Maurizi, N., Monney, P. A., & Pascale, P. (2025) · Heart · doi:10.1136/heartjnl-2024-325043
Genotype-phenotype Correlations in Inherited Cardiomyopathies, their Role in Clinical Decision-making and Implications in Personalized Cardiac Medicine in Multi-omics as Well as Disease Modelling Eras
Taleb, Y. S., Memon, P., Jalbani, A. A., AlMutairi, N., AlMukhaylid, S., Alanazi, N., Al-Garni, A., AlTaweel, M., Khan, M. A., Sabar, M. F., et al. (2024) · ASEAN Journal of Psychiatry · doi:10.54615/2231-7805.24.14.431
Countywide burden, pathology, and genetics of lethal hypertrophic cardiomyopathy: from the POST SCD study
Haghighat, L., Connolly, A. J., Delling, F. N., Abraham, T. P., Moffatt, E., & Tseng, Z. H. (2025) · EP Europace · doi:10.1093/europace/euaf088
Novel Techniques for Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy With Complex Anatomy: A Case Series
Matsuda, J., Tokita, Y., Takano, H., & Asai, K. (2025) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.31549
Clinical manifestation of apical hypertrophic cardiomyopathy by syncope in the elderly
Тарадин, Г. Г., Игнатенко, Г. А., Rakitskaya, I. V., Вадимовна, П. А., Bagriy, V. A., Yefanov, K. I., & Dudnikova, O. A. (2025) · Russian Journal of Cardiology and Cardiovascular Surgery · doi:10.17116/kardio202518021237
The Korean Mavacamten Experience: Small Steps Toward Big Questions in HCM Care
Cho, D. (2025) · Korean Circulation Journal · doi:10.4070/kcj.2025.0147
Impact of cardiac rehabilitation participation on functional capacity in patients with hypertrophic obstructive cardiomyopathy following septal myectomy surgery
Cifci, G., Malterer, K. R., Arendt, E. C., Sawma, T., Ommen, S. R., Schaff, H. V., Squires, R. W., Bonikowske, A. R., & Smith, J. R. (2025) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2025.04.008
Self-citation
From Pixels to Patterns: Radiomic Subphenotyping of Left Ventricular Hypertrophy on Echocardiography
Oikonomou, E. K., & Khera, R. (2025) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.125.018291
Particularidades Clínicas e Ecocardiográficas da Cardiomiopatia Hipertrófica em uma População Brasileira e seu Impacto Prognóstico
Luzuriaga, G. D. C. J., Arteaga-Fernández, E., Hotta, V. T., Ianni, B. M., Nastari, L., Ramires, F. J. A., da Fonseca, G. W. P., Mady, C., Fernandes, F., & Cardoso, J. N. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240640
Predictive Factors for Adverse Cardiac Events and Mortality in Patients with Hypertrophic Cardiomyopathy
Omran, H., Rudolph, T. K., Faber, L., Rudolph, V., & Dimitriadis, Z. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14103546
Longitudinal Outcomes of Left Ventricular Outflow Tract Obstruction in Aortic Stenosis Versus Hypertrophic Obstructive Cardiomyopathy
Ong, J. Y.-S., Li, T. Y., Leow, A. S., Quek, S., Kong, W. K. F., Lin, W., Chai, P., Yeo, T., Wong, R. C.-C., Sia, C., et al. (2025) · Medicina · doi:10.3390/medicina61060971
Diagnostic and Prognostic Testing in Heart Failure
Yellapu, V., Field, P., Thacker, P., & Sheikh, T. (2025) · Medical Clinics of North America · doi:10.1016/j.mcna.2025.04.009
Stress T1 Mapping in Hypertrophic Cardiomyopathy: Investigating Adenosine Administration Time for Adequate Vasodilation
Choo, K. S. (2025) · Journal of the Korean Society of Radiology · doi:10.3348/jksr.2025.0044
Stress T1 Mapping in Hypertrophic Cardiomyopathy: Investigating Adenosine Administration Time for Adequate Vasodilation
Choi, S. I. (2025) · Journal of the Korean Society of Radiology · doi:10.3348/jksr.2025.0017
Targeting cardiomyopathies associated with RASopathies: the role of mitogen-activated protein kinase inhibitors and therapeutic challenges
Botia-Arciniegas, V., Jiménez-Cardozo, N., & Lores, J. (2025) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000569
Abordaje y consumo de recursos sanitarios en la miocardiopatía hipertrófica obstructiva en España: un estudio de la vida real
Villa, R. B., Escobar-López, L., Larena, D. V., Salazar‐Mendiguchía, J., Echeto, A., Hernández, I., Rebollo-Gómez, E., & Gimeno, J. R. (2025) · Revista Española de Cardiología · doi:10.1016/j.recesp.2025.04.004
Cardiac myosin inhibitors: a silver lining for an old disease
Yadav, S., Agstam, S., & Singh, S. (2025) · Open Heart · doi:10.1136/openhrt-2025-003358
Non-sustained Ventricular Tachycardia and Hypertrophic Cardiomyopathy: When to Consider it as a Risk Factor for Sudden Death and Total Mortality?
Faganello, L. S., & Pimentel, M. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250233i
Taquicardia Ventricular Não Sustentada e Cardiomiopatia Hipertrófica: Quando Considerá-la como Fator de Risco para Morte Súbita e Mortalidade Total?
Faganello, L. S., & Pimentel, M. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250233
Influence of heart failure phenotypes on prognosis of patients with hypertrophic cardiomyopathy
Zhao, X., Luo, K., Ma, H., Yang, X., Luo, R., & Li, X. (2025) · Heart & Lung · doi:10.1016/j.hrtlng.2025.05.015
Hypertrophic Cardiomyopathy and Pregnancy
Weldehana, A., Yeneneh, B. T., Zewde, S., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000964
Cardiac phenotype characterization at magnetic resonance imaging in alpha-protein kinase 3–associated hypertrophic cardiomyopathy
Pu, L., Wang, J., Yu, M., Xu, Y., Wan, K., Guo, J., Li, Y., Han, Y., & Chen, Y. (2025) · Journal of Cardiovascular Magnetic Resonance · doi:10.1016/j.jocmr.2025.101930
Multiple-Branch Alcohol Septal Ablation Is Associated with Reduced Cardiovascular Events: Insights from a Trans-Pacific Multicentre Registry
Akita, K., Sato, R., Anzai, A., Sakhuja, R., Fifer, M. A., Shimada, Y. J., & Maekawa, Y. (2025) · CJC Open · doi:10.1016/j.cjco.2025.07.003
Incidence and Healthcare Resource Utilization Among Patients with Hypertrophic Cardiomyopathy Hospitalized for Heart Failure in Japan
Ikeda, Y., Teixeira, B. C., Laurent, T., & Yamamoto, T. (2025) · Cardiology and Therapy · doi:10.1007/s40119-025-00427-3
Personalized Approach May Improve Hypertrophic Cardiomyopathy Diagnosis
Kuehn, B. M. (2025) · Circulation · doi:10.1161/circulationaha.125.074663
The Evolving Landscape of Hypertrophic Cardiomyopathy
Son, J., Nam, J., Choi, K.-U., & Hong, G.-R. (2025) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.06.004
The Role of Medical Therapy in Hypertrophic Cardiomyopathy
Lee, J.-W., Chun, K., Choi, E., & Seo, J. (2025) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.06.005
Phenotyping the Many Faces of Hypertrophic Cardiomyopathy
Geenty, P., Gray, B. R., & Thomas, L. (2025) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.06.001
Hypertrophic Cardiomyopathy in the Absence of “Hypertrophy”
Vega, J., & Urbina, J. (2025) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.06.003
Cardiac magnetic resonance imaging contributing to primary prevention and secondary prevention of sudden cardiac death: Contemporary usefulness and limitations
Amano, Y., Iso, K., Suzuki, Y., & Tachi, M. (2025) · World Journal of Radiology · doi:10.4329/wjr.v17.i7.107140
Direct oral anticoagulants versus vitamin K antagonists in concurrent hypertrophic cardiomyopathy and atrial fibrillation: a meta-analysis
Aboutorabi, M., Ahmad, M., Flora, K., Ferreira, H., Chiu, M. H., Bray, J. J. H., Kumar, N. S., & Providencia, R. A. (2025) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2025.2538563
Multimodality Imaging in the Evaluation of Hypertrophic Cardiomyopathy
Cutts, J. A., & Kramer, C. M. (2025) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.06.006
Ablação Septal Alcoólica no Brasil: Insights do Registro BRASA
Lopes, M. A. A. A. D. M., Viana, M., Nóbrega, J., de Medeiros, H. N. A. A., & de Oliveira, G. M. M. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250312
Cardiomyopathy as indication for pediatric heart transplantation
Raissadati, A., Tolani, D., & Profita, E. (2025) · JHLT Open · doi:10.1016/j.jhlto.2025.100360
Totally thoracoscopic transmitral versus transaortic septal myectomy for hypertrophic cardiomyopathy: A propensity score−matched comparative study
Lyu, C., Gong, D., Xie, Y., Nie, H., Deng, L., Li, Y., Sοng, Y., & Wang, X. (2025) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2025.08.004
Hypertrophic cardiomyopathy occurred after successful surgical correction of supravalvular aortic stenosis: a case report of Williams–Beuren syndrome
Yu, H., Ruan, Y., Sun, M., Li, T., & Nie, Z. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1580272
Alcohol Septal Ablation in Brazil: Insights from the BRASA Registry
Lopes, M. A. A. A. D. M., Viana, M., Nóbrega, J., de Medeiros, H. N. A. A., & de Oliveira, G. M. M. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250312i
Monitoring Beta-Blocker Therapy in Adolescents with Exercise-Induced Intraventricular Gradients Using Exercise Stress Echocardiography
Cotrim, N., Café, H. M., Guardado, J. H., Cordeiro, P., Martins, R., Cotrim, H., & Cotrim, C. (2025) · Biomedicines · doi:10.3390/biomedicines13082035
Case Report: Point of Care Ultrasound for Bedside Diagnosis of Hypertrophic Cardiomyopathy in the Post-anesthesia Care Unit
Dabo-Trubelja, A., & Fischer, G. W. (2025) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-02010-2
Phenotypic overlap in apical hypertrophic cardiomyopathy: one size does not fit all
Narvaez-Guerra, O. D., Botros, M. B., Offord, E., & Aurigemma, G. P. (2025) · BMJ Case Reports · doi:10.1136/bcr-2025-266500
Cardiopulmonary Exercise Testing in Hypertrophic Cardiomyopathy: Refining a Proven Tool for Better Risk Prognostication
Ilonze, O. J., & Mazimba, S. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.044210
Mitral Transcatheter Edge‐to‐Edge Repair in Symptomatic Hypertrophic Cardiomyopathy: A Systematic Review
Ahmed, A. O. E., Webber, F. M., Perumalla, H. S., Abid, S., Baniowda, M., Arango, J., & Dyal, M. D. (2025) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.70132
Disparities in Heart Failure Epidemiology, Diagnosis, Management, and Outcomes
Yan, A., Srivastava, P. K., Vucicevic, D., Agarwal, M. A., Ziaeian, B., Fonarow, G. C., Nsair, A., & Shahandeh, N. (2025) · Cureus · doi:10.7759/cureus.91788
Editorial: Experience matters: Optimizing alcohol septal ablation outcomes in obstructive hypertrophic cardiomyopathy
Mauriello, A., Correra, A., Russo, V., & D’Andrea, A. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133890
HYPERTROPHIC CARDIOMYOPATHY IN ATHLETES - A LITERATURE REVIEW
Smyła-Gruca, W., Gruca, M., Kost, K., Boczek, S., & Herba, M. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3813
Multimodality Imaging in Hypertrophic Cardiomyopathy
Peters, M. G., Schweitzer, M., & Galazka, P. Z. (2025) · Cardiology Clinics · doi:10.1016/j.ccl.2025.07.007
Contrast echocardiography with a physiological contrast agent for alcohol septal ablation
İlkay, E., Saglam, Y., Sarıçam, E., Karaduman, B. D., Kaçmaz, F., Yakici, A., Koca, C., Polat, M., Türinay, Z. Ş., & Erdöl, M. A. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1634818
Assessment of Right Atrial Function in Apical Hypertrophic Cardiomyopathy by Two-Dimensional Speckle Tracking Imaging
朱, 江. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1592557
Perioperative point-of-care ultrasound
Wakefield, B. J., Kumar, N. S., & Shaw, A. (2025) · Journal of Translational Critical Care Medicine · doi:10.1097/jtccm-d-25-00008
Middle-aged Man with Syncope
Sharma, P., Bhasin, D., & Raj, R. (2025) · Journal of Postgraduate Medicine Education and Research · doi:10.5005/jp-journals-10028-1747
Competitive athletes with hypertrophic or dilated cardiomyopathy: sports eligibility according to the current Italian guidelines
Cavigli, L., Ragazzoni, G. L., Cecchi, F., Olivotto, I., Pelliccia, A., Sinagra, G., & D’Ascenzi, F. (2025) · The Journal of Sports Medicine and Physical Fitness · doi:10.23736/s0022-4707.25.16974-0
Electrocardiographic precedence with rapid anatomical progression in apical hypertrophic cardiomyopathy: a case report
Zheng, X. F. S. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05200-x
Treatment With Myosin Inhibitor in a Patient With Symptomatic Hypertrophic Cardiomyopathy With Isolated Right Ventricular Obstruction
Schwegel, N., Santner, V., Kolesnik, E., Schmid, J., Tóth, G. G., & Verheyen, N. (2025) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.012801
The Relationship between Symptom Burden and Myocardial Fibrosis in Patients with Hypertrophic Cardiomyopathy.
Güler, A., Türkmen, I., Tülüce, S. Y., Aydın, S., Atmaca, S., Şahin, H., Suna, M., Gündogdu, M. C., Demirci, G., Tekin, M., et al. (2025) · Europe PMC (PubMed Central) · doi:10.6515/acs.202509_41(5).20250531b

Authors: Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., Joglar, J. A., Khan, S. S., Kim, J. J., Kittleson, M. M., Krittanawong, C., Martinez, M. W., Mital, S., Naidu, S. S., Saberi, S., Semsarian, C., Times, S., & Waldman, C. B.
Affiliations: American Medical Society for Sports Medicine (US)
HRS representative.
Lay stakeholder representative.
AHA/ACC Joint Committee on Clinical Practice Guidelines liaison.
American Hospital Association (US)
PACES representative.
Joint ACC/AHA staff representative.
ORCID: Ommen, Steve R.
Ho, Carolyn Y.
Asif, Irfan M.
Balaji, Seshadri
Burke, Michael A.
Day, Sharlene M.
Dearani, Joseph A.
Ferrari, Victor A.
Joglar, José A.
Khan, Sadiya S.
Kim, Jeffrey J.
Kittleson, Michelle M.
Krittanawong, Chayakrit
Martinez, Matthew W.
Mital, Seema
Naidu, Srihari S.
Saberi, Sara
Semsarian, Christopher
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2024-06-04
Volume: 149
Issue: 23
Pages: e1239-e1311
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/cir.0000000000001250
OpenAlex: W4396750647
Cited by: 807
References: 514
Citations by year: 2026: 353 · 2025: 372 · 2024: 82
FWCI: 226.55
Type: journal article
Language: en
Update notices: correction (2024-08-19)
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords: hypertrophic cardiomyopathy, disease management, inherited heart disease, diagnosis, treatment guidelines, American Heart Association, American College of Cardiology, American Society of Echocardiography
MeSH terms: American Heart Association, Cardiology, Cardiomyopathy, Hypertrophic, Humans, United States, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks